MATUCCI CERINIC, MARCO
 Distribuzione geografica
Continente #
EU - Europa 730
AS - Asia 596
NA - Nord America 237
OC - Oceania 4
SA - Sud America 4
Totale 1.571
Nazione #
RU - Federazione Russa 462
SG - Singapore 450
US - Stati Uniti d'America 234
CN - Cina 123
IT - Italia 123
SE - Svezia 76
FR - Francia 16
DE - Germania 11
FI - Finlandia 11
GB - Regno Unito 10
TR - Turchia 8
NL - Olanda 7
IN - India 6
UA - Ucraina 5
PE - Perù 4
HU - Ungheria 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SA - Arabia Saudita 3
TW - Taiwan 3
ES - Italia 2
HK - Hong Kong 2
MX - Messico 2
AU - Australia 1
CA - Canada 1
GR - Grecia 1
IL - Israele 1
Totale 1.571
Città #
Singapore 255
Moscow 144
Shanghai 104
Boardman 44
Milan 30
New York 27
Ashburn 19
Clifton 19
Lawrence 17
Princeton 17
Santa Clara 17
Helsinki 8
Los Angeles 8
Council Bluffs 4
Istanbul 4
Lima 4
London 4
Munich 4
Paris 4
Amadora 3
Ancona 3
Cormons 3
Florence 3
Izmir 3
Lappeenranta 3
New Taipei City 3
Osimo 3
Padova 3
Palmerston North 3
Pietramelara 3
Riyadh 3
Rome 3
Seattle 3
Southam 3
Spijkenisse 3
Vaprio d'Adda 3
Angers 2
Bitonto 2
Busto Arsizio 2
Enschede 2
Galliate 2
Hong Kong 2
Hyde Park 2
Hyderabad 2
Iztapalapa 2
L’Aquila 2
Mantova 2
Marana 2
Naples 2
New Delhi 2
Nocera Umbra 2
Palermo 2
Pamplona 2
Pontedera 2
Pune 2
Pécs 2
San Francisco 2
San Mateo 2
Santa Maria a Vico 2
St Petersburg 2
Stezzano 2
Trento 2
Vignola 2
Wandsworth 2
Washington 2
Amsterdam 1
Aradeo 1
Athens 1
Beersheba 1
Bollate 1
Canberra 1
Capaccio 1
Catania 1
Certaldo 1
Correggio 1
Fiesole 1
Hamm 1
Hangzhou 1
Kilburn 1
Kistarcsa 1
Konya 1
Laurel 1
Merselo 1
Nuremberg 1
Parma 1
San Casciano in Val di Pesa 1
San Giovanni In Persiceto 1
San Jose 1
Secaucus 1
Trumbull 1
Totale 867
Nome #
Cardiac magnetic resonance in systemic sclerosis myocarditis: the value of T2 mapping to detect myocardial inflammation 27
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 22
The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis 22
Myocarditis in anti-synthetase syndrome: clinical features and diagnostic modalities 19
Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology 18
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 17
"Atlas of Capilaroscopy in Rheumatic Diseases" - Chapter: The microcirculation and Rheumatic Diseases 16
Geographical heterogeneity of clinical and serological phenotypes of systemic sclerosis observed at tertiary referral centres. The experience of the Italian SIR-SPRING registry and review of the world literature 16
Myelomonocytic cells in giant cell arteritis activate trained immunity programs sustaining inflammation and cytokine production 16
Anakinra for the Treatment of Antisynthetase Syndrome: A Monocentric Case Series and a Systematic Literature Review 16
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 16
Riabilitazione dell’articolazione temporomandibolare (atm) in pazienti con sclerosi sistemica (ssc): confronto tra due protocolli. Risultati preliminari 15
Systemic Sclerosis Association with Malignancy 15
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition 15
Intravenous immunoglobulins reduce skin thickness in systemic sclerosis: evidence from Systematic Literature Review and from real life experience 15
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies 15
Safety and efficacy of rituximab biosimilar (CT-P10) in systemic sclerosis: an Italian multicentre study 14
Severe acute respiratory syndrome coronavirus-2-induced flare of systemic sclerosis 14
Adherence to the Mediterranean Diet in Italian Patients With Systemic Sclerosis: An Epidemiologic Survey 13
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 13
Improvements of vascular outcomes in systemic sclerosis: halfway through, but still far to go 13
Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors 12
Myocarditis as a manifestation of Erdheim–Chester Disease: successful use of anti- IL1 and BRAF inhibitor combination therapy 12
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 12
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement 12
Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort 11
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 10
Very early and early diagnosis of systemic sclerosis 10
LA PROSPETTIVA DEI PAZIENTI REUMATICI SULL’UTILITÀ DELLA TELEMEDICINA PER IL FOLLOW UP DELLA MALATTIA: ESPERIENZE E PROBLEMATICHE ORGANIZZATIVE DURANTE LA PANDEMIA 10
The Italian version of the Hand Mobility in Scleroderma (HAMIS) test: evidence for its validity and reliability 10
"Autoimmunity" - Chapter: Autoantibodies in systemic sclerosis 10
Very early systemic sclerosis 10
ASSESSMENT OF HEALTH LITERACY IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 9
GLI INTERVENTI INFERMIERISTICI RIVOLTI AI PAZIENTI AFFETTI DA MALATTIE REUMATICHE SOTTOPOSTI A TERAPIA CON FARMACI BIOLOGICI: REVISIONE SISTEMATICA DELLA LETTERATURA 9
Open questions on the management of targeted therapies for the treatment of systemic sclerosis-interstitial lung disease: results of a EUSTAR survey based on a systemic literature review 9
Cardiac involvement, a threatening very early manifestation of systemic sclerosis: evidence from VEDOSS patients 9
Screening for pulmonary arterial hypertension in systemic sclerosis: A systematic literature review 9
Stressful life events at the onset and during the evolution of systemic sclerosis 9
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 8
Early diagnosis of systemic sclerosis, where do we stand today? 8
Systematic Literature Review and Expert Opinion for the Use of Viscosupplementation with Hyaluronic Acid in Different Localizations of Osteoarthritis 8
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 8
Shoulder impingement syndrome in water polo players: muscle shortening manoeuvre controls pain intensity, recovers function and normalizes sonographic parameters 8
Impairment in the telocyte/CD34+ stromal cell network in human rheumatoid arthritis synovium 8
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study 8
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 8
Computed Tomography Predictors of Mortality or Disease Progression in Systemic Sclerosis–Interstitial Lung Disease: A Systematic Review 8
Outcomes of limited cutaneous systemic sclerosis patients: Results on more than 12,000 patients from the EUSTAR database 8
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 8
GASTROINTESTINAL INVOLVEMENT AND QUALITY OF LIFE IN A COHORT OF SYSTEMIC SCLEROSIS (SSC) PATIENTS 8
The target on B cells in Systemic Sclerosis: a “midsummer dream” to extinguish inflammation and prevent early disease progression to fibrosis 8
The multifaceted problem of pulmonary arterial hypertension in systemic sclerosis 8
Performance of ultra-high-frequency ultrasound in the evaluation of skin involvement in systemic sclerosis: A preliminary report 7
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management 7
Lymphatic Endothelial-to-Myofibroblast Transition: A Potential New Mechanism Underlying Skin Fibrosis in Systemic Sclerosis 7
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population 7
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis 7
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort 7
In search for the ideal anatomical composition of vascularised human skin equivalents for systemic sclerosis translational research: should we recruit the telocytes? 7
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis 7
Systemic sclerosis sine scleroderma: clinical and serological features and relationship with other cutaneous subsets in a large series of patients from the national registry 'SPRING' of the Italian Society for Rheumatology 7
One year later: The case of tocilizumab in COVID-19 7
Iloprost use and medical management of systemic sclerosis-related vasculopathy in Italian tertiary referral centers: results from the PROSIT study 7
Extracellular Lactic Acidosis of the Tumor Microenvironment Drives Adipocyte-to-Myofibroblast Transition Fueling the Generation of Cancer-Associated Fibroblasts 7
Decreased Serum Levels of SIRT1 and SIRT3 Correlate with Severity of Skin and Lung Fibrosis and Peripheral Microvasculopathy in Systemic Sclerosis 7
Treatment For Metatharsalgia By Plantar Insoles And Silicone Orthosis For Toes In Patients With Rheumatoid Arthritis And Osteoarthritis: A Cross-Over Study 7
Successful pregnancies but a higher risk of preterm births in patients with systemic sclerosis: An Italian multicenter study 7
Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum 7
A candidate gene study reveals association between a variant of the SRp55 splicing factor gene and systemic sclerosis 7
The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress 7
Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase 7
Soluble guanylate cyclase stimulation fosters angiogenesis and blunts myofibroblast-like features of systemic sclerosis endothelial cells 6
A SYSTEMATIC LITERATURE REVIEW (SLR) ON NURSING SENSITIVE OUTCOMES IN SYSTEMIC SCLEROSIS 6
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 6
Lung involvement in systemic sclerosis 6
Potential Role of JAK Inhibitors in the Treatment of Systemic Sclerosis-Associated Interstitial Lung Disease: A Narrative Review from Pathogenesis to Real-Life Data 6
Combination of denosumab and biologic DMARDs in inflammatory muscle-skeletal diseases and connective tissue diseases 6
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 6
Pleuroparenchymal fibroelastosis in patients affected by systemic sclerosis: What should the rheumatologist do? 6
Pleuroparenchymal fibroelastosis in rheumatic autoimmune diseases: a systematic literature review 6
Study of vitamin D status and vitamin D receptor polymorphisms in a cohort of Italian patients with juvenile idiopathic arthritis 6
Proangiogenic effects of soluble α-Klotho on systemic sclerosis dermal microvascular endothelial cells 6
A custom-made splint is useful in the treatment of Osteoarthritis of the trapeziometacarpal joint 6
AB1540-HPR NURSING INTERVENTIONS FOR RHEUMATIC MUSCULOSKELETAL DISEASES (RMDS) PATIENTS ON BIOLOGIC THERAPY: A SYSTEMATIC LITERATURE REVIEW (SLR) 6
A new avenue in the pathogenesis of systemic sclerosis: the molecular interface between the endothelial and the nervous systems 6
Extracellular lactic acidosis drives reprogramming of human subcutaneous adipocytes toward pathogenic myofibroblasts 6
Decreased circulating lymphatic endothelial progenitor cells in digital ulcer-complicated systemic sclerosis 6
EFFICACY OF A SELF-TREATMENT PROTOCOL FOR FACE AND TEMPOROMANDIBULAR JOINTS REHABILITATION IN SYSTEMIC SCLEROSIS 6
Ultrasound assessment of splanchnic circulation in Systemic Sclerosis: a non-invasive approach for the study of bowel vasculopathy? 6
Edema-like marrow signal intensity: a narrative review with a pictorial essay 6
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 6
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today 6
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 6
Persistence of remission after lengthening of golimumab in inflammatory joint diseases 6
Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis 6
A Sonographic (Us) Evaluation Of Ligaments Of Sacroiliac Joint In Healthy Subjects 6
Disease activity assessment of rheumatic diseases during pregnancy: a comprehensive review of indices used in clinical studies 6
A two-step immunomagnetic microbead-based method for the isolation of human primary skin telocytes/CD34+ stromal cells 6
Alfabetizzazione sanitaria e pazienti affetti da Sclerosi Sistemica 6
The contribution of epigenetics to the pathogenesis and gender dimorphism of systemic sclerosis: a comprehensive overview 6
Totale 939
Categoria #
all - tutte 33.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 0 3 0 0 0 0 0
2021/202238 0 0 11 3 1 3 1 0 0 16 1 2
2022/2023170 42 28 9 1 3 16 29 20 15 0 6 1
2023/20241.248 4 9 14 20 18 574 222 176 10 26 48 127
2024/2025941 941 0 0 0 0 0 0 0 0 0 0 0
Totale 2.402